Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
1 clinical trials · Condition
◉ Watch Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
| Record | Firm | Date |
|---|---|---|
| Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System (NCT05211336) | National Cancer Institute (NCI) | 2022-04-19 |
Track Aggressive B-cell Lymphoma With Secondary Involvement of the CNS automatically
Every clearance here is in the API, with alerts when new ones post.